Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 27 (HNRNPA1P27) is a non-protein-coding pseudogene related to the functional HNRNPA1 gene. Pseudogenes like HNRNPA1P27 are segments of DNA similar to known genes but are not translated into functional proteins due to mutations, lack of regulatory elements, or other impairments[1][9]. While certain pseudogenes have been implicated in the regulation of gene expression (e.g., some serve as competitive endogenous RNAs or interact with RNA-binding proteins), there is currently no evidence supporting direct biological or disease relevance of HNRNPA1P27. It is not considered a drug target or a biomarker, nor is it associated with established molecular or therapeutic functions[1][5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 27 (HNRNPA1P27).